Delivering timely service and evidence-informed resources to people in BC and the Yukon facing cancer and those involved in oncology care or research.
c.1 BC Cancer Agency KEL Library | Available |
c.1 BC Cancer Agency VAN Library | Available |
c.1 BC Cancer Agency VAN Library | Available |
Contents:; Radiation therapy effects on the central nervous system / Cramer, Chan, Kirkpatrick -- Radiation therapy effects in head and neck cancer / Galloway, Yom -- Radiation therapy effects on the thorax / Kaidar, Person, Zagar, Marks -- Radiation therapy effects in breast cancer / Boggs, De Los…
c.1 BC Cancer Agency KEL Library | Available |
c.1 BC Cancer Agency ARHCC Cancer Info Ctr | Available | ||
c.1 BC Cancer Agency PG Cancer Info Ctr | Available | ||
c.1 BC Cancer Agency KEL Cancer Info Ctr Missing | Available | ||
c.1 BC Cancer Agency VAN Cancer Info Ctr | Available | ||
c.1 BC Cancer Agency VAN Library | Available | ||
c.1 BC Cancer Agency VIC Cancer Info Ctr Missing | Available |
c.1 BC Cancer Agency ARHCC Cancer Info Ctr | Available | ||
c.1 BC Cancer Agency KEL Cancer Info Ctr | Available | ||
c.1 BC Cancer Agency VIC Cancer Info Ctr | Available | ||
c.1 BC Cancer Agency VAN Library | Available |
c.1 BC Cancer Agency ARHCC Cancer Info Ctr | Available | ||
c.1 BC Cancer Agency VIC Cancer Info Ctr | Available | ||
c.1 BC Cancer Agency VAN Library | Available | ||
c.1 BC Cancer Agency KEL Cancer Info Ctr | Available |
c.1 BC Cancer Agency VAN Library | Available |
c.1 BC Cancer Agency VAN Library | Available |
c.1 BC Cancer Agency VAN Library | Available | ||
c.2 BC Cancer Agency VAN Library | Available |
Coronary artery disease, peripheral vascular disease (PVD), renal artery stenosis, lung cancer screening, pulmonary embolism (PE), carotid artery disease, cerebral aneurysms, headaches, head injuries, seizures, stroke, arteriovenous malformations (AVMs), and urinary tract calculi screening
c.1 BC Cancer Agency KEL Library | Available |
c.1 BC Cancer Agency VAN Library | Available |
Radiation safety aspects of brachytherapy for prostate cancer using permanently implanted sources. A report of ICRP publication 98. Ann ICRP> 2005; 35(3) : iii-vi, 3-50. Review Erratum in: Ann ICRP 2005; 35(4) :141.